FDA Inspection
Quality CDMOQuality CDMO – FDA Inspection, Jun 16, 2023
Record Details
This FDA Inspection record concerns Quality CDMO, with an inspection on June 16, 2023, covering drugs.
- Company
- Quality CDMO
- Inspection Date
- June 16, 2023
View Company Profile
ID · cb25f1a6-79a6-42c4-bbac-9bbaae232c2e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1208195
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.111Establishment of time limitations
- 21 CFR 211.22(a)Approve or reject components, products
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Quality CDMO
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 12, 2026 | Not classified | Dallas District Office |
Other documents for Quality CDMO
- FDA Inspection 1301370 - 2026-02-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.